62 related articles for article (PubMed ID: 8239684)
41. Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary results.
Comella P; Abate G; Comella G; Bruni GS; Zarrilli D; Pergola M
Tumori; 1980 Dec; 66(6):749-56. PubMed ID: 7233568
[TBL] [Abstract][Full Text] [Related]
42. Combination chemotherapy with irinotecan and adriamycin for refractory and relapsed non-Hodgkin's lymphoma.
Saotome T; Takagi T; Sakai C; Kumagai K; Tamaru J
Ann Oncol; 2000 Jan; 11(1):115-6. PubMed ID: 10690400
[TBL] [Abstract][Full Text] [Related]
43. [Post therapeutic myeloblastic leukemia in non-Hodgkin's lymphoma].
Maekawa I; Kawamura T; Miyake T
Gan No Rinsho; 1984 Sep; 30(11):1422-8. PubMed ID: 6594532
[TBL] [Abstract][Full Text] [Related]
44. Effect of tamoxifen on the pharmacokinetics of doxorubicin in patients with non-Hodgkin's lymphoma.
El-Yazigi A; Berry J; Ezzat A; Wahab FA
Ther Drug Monit; 1997 Dec; 19(6):632-6. PubMed ID: 9421103
[TBL] [Abstract][Full Text] [Related]
45. Circadian pharmacokinetics of methotrexate.
Robinson BA; Begg EJ; Colls BM; Jeffery GM; Sharman JR
Cancer Chemother Pharmacol; 1989; 24(6):397-9. PubMed ID: 2791195
[TBL] [Abstract][Full Text] [Related]
46. A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
Takagi T; Sampi K; Sawada U; Sakai C; Oguro M
Int J Hematol; 1993 Jan; 57(1):67-71. PubMed ID: 8477064
[TBL] [Abstract][Full Text] [Related]
47. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
48. [Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
Avilés A; Díaz-Maqueo JC; Torras V; Rodríguez L; López Vancell D
Sangre (Barc); 1990 Aug; 35(4):245-9. PubMed ID: 1703327
[TBL] [Abstract][Full Text] [Related]
49. [Modified CHOP therapy in patients with non-Hodgkin's lymphoma].
Misago M; Chiba S; Tsukada J; Nakata K; Sato T; Nagata K; Mori N; Wake A; Ogawa R; Kikuchi M
Gan To Kagaku Ryoho; 1991 May; 18(6):1007-11. PubMed ID: 2029185
[TBL] [Abstract][Full Text] [Related]
50. [Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas].
Takagi T; Sakai C; Oguro M
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2191-4. PubMed ID: 8239684
[TBL] [Abstract][Full Text] [Related]
51. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
52. [Chemotherapy for non-Hodgkin's lymphoma].
Kuraishi Y; Usui N; Dobashi N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2210-6. PubMed ID: 9881077
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]